[{"id":"da6e025c-4984-4fb7-b17d-e6ee42cb73bd","acronym":"DecipHER","url":"https://clinicaltrials.gov/study/NCT05504707","created_at":"2022-08-17T13:55:07.493Z","updated_at":"2024-07-02T16:35:05.685Z","phase":"Phase 1","brief_title":"DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer","source_id_and_acronym":"NCT05504707 - DecipHER","lead_sponsor":"H. Lee Moffitt Cancer Center and Research Institute","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 negative","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER2- and HER3-primed dendritic cells"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 08/26/2022","start_date":" 08/26/2022","primary_txt":" Primary completion: 06/01/2024","primary_completion_date":" 06/01/2024","study_txt":" Completion: 04/01/2025","study_completion_date":" 04/01/2025","last_update_posted":"2024-05-06"}]